InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Jenne Kyle. Insider active across 1 company, notably Ionis Pharmaceuticals INC. Cumulatively, 5 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €313k. History available since 15 April 2025. The latest transaction was disclosed on 15 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Jenne Kyle is EVP, Chf GL Pdt Str Ofcr at Ionis Pharmaceuticals INC, listed on XNAS. The record shows 5 filings in total. Across the 5 recent filings available, sales total EUR 312736, the period runs from 2025-04-17 to 2026-04-17, and the most common transaction nature is option exercise.